Cefalexin 250mg capsules

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Cefalexin

Available from:

Waymade Healthcare Plc

ATC code:

J01DB01

INN (International Name):

Cefalexin

Dosage:

250mg

Pharmaceutical form:

Oral capsule

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 05010201

Patient Information leaflet

PACKAGE LEAFLET: INFORMATION FOR THE USER
CEFALEXIN CAPSULES 250 MG
CEFALEXIN CAPSULES 500 MG
(cefalexin monohydrate)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you. Do not pass it on
to
others. It may harm them, even if their symptoms are the
same as yours.
-
If any of the side effects gets serious, or if you notice any side
effects not listed in this leaflet, please tell your doctor.
IN THIS LEAFLET:
1. What Cefalexin Capsules are and what they are used for
2. Before you take Cefalexin Capsules
3. How to take Cefalexin Capsules
4. Possible side effects
5. How to store Cefalexin Capsules
6. Further information
1. WHAT CEFALEXIN CAPSULES ARE AND WHAT THEY ARE
USED FOR
Cefalexin Capsules contain cefalexin as the active ingredient, which
belongs to a class of antibiotics called ‘cephalosporins’. The
capsules
are used to treat a variety of bacterial infections. These include
infections of the airways from nose to lungs, ear, bones and joints,
and urine or reproduction systems, incuding inflammation of the
prostate gland. They are also used to treat dental infections.
2. BEFORE YOU TAKE CEFALEXIN CAPSULES
DO NOT TAKE CEFALEXIN CAPSULES IF YOU HAVE:
•
an allergy (hypersensitivity) to the cephalosporin or penicillin
group of antibiotics, or to any of the ingredients in the product
_(see Section 6)._
•
porphyria; a hereditary metabolic disorder.
TAKE SPECIAL CARE WITH CEFALEXIN CAPSULES IF YOU HAVE:
•
kidney problems.
•
inflammation of the large intestine, symptoms include:
diarrhoea, pain and fever.
You should be aware that Cefalexin Capsules may give a false result
for:
•
certain blood tests
•
tests for glucose in the urine.
TAKING OTHER MEDICINES
Please inform your doctor if you are taking or have recently taken
any other medicines, including those obtained without a
prescription.
In particular, tell your doctor i

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Cefalexin 250 mg Capsules
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
250 mg Cefalexin (as monohydrate)
For excipients, see 6.1
3
PHARMACEUTICAL FORM
Capsules, hard
Size 2 grey/orange capsule containing white powder printed CHX 250.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Cefalexin is a semi synthetic cephalosporin antibiotic for oral
administration.
Cefalexin is indicated in the treatment of the following infections:
Respiratory tract infections; otitis media; skin and soft tissue
infections;
bone and joint infections; genito-urinary infections, including acute
prostatitis and dental infections.
Cefalexin is active against the following organisms in vitro:
β
-
haemolytic streptococci; staphylococci, including coagulase-positive,
coagulase-negative and penicillinase-producing strains; Streptococcus
pneumoniae; Escherichia coli; Proteus mirabilis; Klebsiella species,
Haemophilus influenzae; Branhamella catarrhalis.
Most strains of enterococci (Streptococcus faecalis) and a few strains
of
staphylococci are resistant to cefalexin. Cefalexin is inactive
against
most strains of enterobacter, morganella morganii, pr. Vulgaris,
Colstridium difficule, and the following species: legionella,
campylobacter , pseudomonas or herellea species. When tested by in
vitro methods, staphylococci exhibit cross-resistance between
cefalexin
and methicillin-type antibiotics.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_ _
_Adults _
1-4g daily in divided doses; most infections will respond to a dosage
of
500mg every 8 hours.
For skin and soft tissue infections, streptococcal pharyngitis and
mild,
uncomplicated urinary tract infections, the usual dosage is 250mg
every
6 hours, or 500mg every 12 hours.
More severe infections, or those caused by less susceptible organisms
may need larger doses.
If daily doses of cefalexin greater than 4g are required parenteral
cephalosporins, in appropriate doses, should be considered.
_Elderly and patients with impaired renal func